One hundred clinical isolates, including Escherichia coli, Serratia marcescens, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus vulgaris and Proteus mirabilis, were exposed to carbapenems (imipenem, panipenem, meropenem and biapenem) at 0.5 x MIC for 3 h, then their morphology was examined and endotoxin release determined. Ceftazidime, which induces filament formation, was used as a control. Scanning electron microscopy showed that these carbapenems induced formation of spherical or ovoid cells, except for P. aeruginosa treated with meropenem and biapenem; these latter cells had a 'bulge' midway along them and we have termed them 'oval-centred'. There was a relationship between morphology and the amount of endotoxin released following exposure to carbapenems or ceftazidime. Of all the species investigated, P. aeruginosa showed the most variable morphological changes. P. aeruginosa exposed to biapenem were longer oval-centred in shape, and released significantly more endotoxin than those exposed to imipenem, panipenem (spherical) or meropenem (shorter oval-centred cells) (P = 0.030, 0.017 and 0.002, respectively). In all strains except P. aeruginosa, carbapenems induced significantly less endotoxin release than ceftazidime (P < 0.05). We studied 100 clinical isolates, including Escherichia coli, Serratia marcescens, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus vulgaris and Proteus mirabilis, to examine what morphological changes were induced by imipenem, panipenem, meropenem and biapenem, and to determine endotoxin release by selected strains that showed prominent morphological changes.
Introduction
Antibiotic-mediated release of endotoxin (lipopolysaccharide; LPS) from Gram-negative bacteria has been reported often. [1] [2] [3] [4] [5] Although various bactericidal antibiotics are highly effective against Gram-negative bacteria in vitro, infections caused by these bacteria are still associated with high mortality. 6 Poor penetration into the infected tissues and the propensity of antibiotics to induce release of endotoxin into the circulation may, in part, be responsible for this.
Previous studies have demonstrated that endotoxin is released as a consequence of antibacterial action. [7] [8] [9] [10] [11] [12] [13] [14] Antibiotics vary in their ability to induce endotoxin release, probably as a result of their differing mechanisms of antibacterial activities. 11 Penicillin-binding proteins (PBPs), especially PBP-1, -2 and -3, are the primary targets of -lactam antibiotics in Gram-negative bacteria. They catalyse the terminal stages in the assembly of the peptidoglycan network of the bacterial cell wall. Inhibition of PBP-1 is associated with rapid killing and lysis, whereas inhibition of PBP-2 and PBP-3 produces spherical, nongrowing cells and long filaments, respectively. 15, 16 In general, carbapenems such as imipenem, panipenem and biapenem have a high affinity for both PBP-1 and PBP-2, and cause the bacilli to form round cells (spheroplasts), whereas ceftazidime, a cephalosporin, has a high selective affinity for PBP-3, and induces the formation of long filaments. 11, 17, 18 Meropenem, another carbapenem, has a very high affinity for both PBP-2 and PBP-3, resulting in the formation of filaments with or without an oval 'bulge' at the centre. 19, 20 Endotoxin release induced by various antibiotics is associated with morphological changes. 7, 8, 19 Carbapenem-induced morphological changes and endotoxin release have been studied previously. [17] [18] [19] [20] [21] However, results have been drawn from only a limited number of strains, and extensive morphological studies using clinical isolates are lacking. 
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Antibiotics
The antibiotics used were ceftazidime (Japan Glaxo, Tokyo, Japan), imipenem (Banyu Pharmaceutical, Tokyo, Japan), panipenem (Sankyo, Tokyo, Japan), meropenem (Sumitomo Pharmaceutical, Osaka, Japan) and biapenem (Lederle Japan, Tokyo, Japan).
Susceptibility testing
MICs were determined for each strain by an agar dilution method as described by the National Committee for Clinical Laboratory Standards. 22 Susceptibility testing was performed on Mueller-Hinton agar and Mueller-Hinton broth (Difco) in accordance with the manufacturer's instructions.
Morphological studies
The morphology of all clinical isolates was evaluated by phase-contrast microscopy on a wet mount. One colony was inoculated into Mueller-Hinton broth (5 mL) and cultured at 37°C. A portion of the inoculum (10 L; approximately 10 6 cfu/mL) was plated on to MuellerHinton agar containing appropriate antibiotics (0.5 MIC) and incubated at 37°C for 3 h. The preparation was fixed with Karnovsky's fixative (paraformaldehyde (2%) and glutaraldehyde (2.5%) in 0.05 M phosphate buffer (pH 7.4)).
Scanning electron microscopy
Isolates on Mueller-Hinton agar were exposed for 3 h to antibiotics and their morphology was examined by scanning electron microscopy (SEM) as follows. The bacteria were fixed with Karnovsky's fixative at 4°C for 16 h, stained with 1% osmium tetroxide and then dehydrated for 15 min each in increasing concentrations of ethanol (70, 80, 90, 95 and 100%) followed by isoamylacetate (100%) for 15 min. They were critical-point dried (HCP-2 critical point dryer; Hitachi, Tokyo, Japan), carbon-coated (JEE-450D; Jeol, Akishima, Japan) for 5 s and platinumcoated with Ion Coating IB-2 (Eiko Engineering, Hitachinaka, Japan) for 3 min. Finally, specimens were examined with a Hitachi S-800 electron microscope at an accelerating voltage of 10 kV.
Endotoxin release studies
Glass test tubes were rendered endotoxin-free by heating them at 250°C for 3 h. Sterile, endotoxin-free plasticware (specimen containers and pipette tips) was used for all endotoxin assays. Bacteria were inoculated into MuellerHinton broth (5 mL) and incubated at 37°C for 5 h. Cultures were then diluted 1000-fold in fresh MuellerHinton broth (10 mL) and incubated at 37°C for 3 h in the presence of 0.5 MIC of antibiotics.
The amount of free LPS in samples was determined after removing bacterium-bound LPS by filtration through an endotoxin-free 0.45 m filter. 11 The filtrates were immediately stored at -70°C. To quantify bacteria, aliquots were then serially diluted in PBS (pH 7.4), and 0.1 mL from each dilution was plated on to Mueller-Hinton agar plates. After overnight incubation at 37°C, cfu/mL were counted.
Endotoxin assay
The activity of endotoxin was determined by a chromogenic endotoxin-specific assay using Limulus coagulation enzyme (ES test, Seikagaku-Kogyo, Tokyo, Japan). Endotoxin concentrations were calculated by comparison with the reference endotoxin, E. coli O111:B4 LPS. The samples were serially diluted as needed in endotoxin-free physiological saline (Otsuka Pharmaceutical, Tokyo, Japan) from 1:100 to 1:1,000,000 to achieve concentrations in the range 0.01-0.5 g/L, within which there is a linear relationship between E. coli endotoxin O111:B4 concentration and spectrophotometric absorbance.
Statistical analysis
Results are expressed as mean S.E. Paired data were compared using a two-tailed paired t-test. P values of 0.05 were considered significant.
Results
Antibiotic susceptibility
The results of susceptibility tests are summarized in Table  I . All E. coli strains were susceptible to ceftazidime and to the carbapenems investigated ( 8 mg/L and 4 mg/L, respectively). Five S. marcescens strains were especially highly resistant to all of these antibiotics. 23 All except one of the K. pneumoniae strains were sensitive to these antibiotics; one strain was resistant to ceftazidime but not to carbapenems. 24, 25 Strains of other species showed varying patterns of susceptibility. All strains, except some P. aeruginosa strains, were sensitive to meropenem. Table II summarizes the morphological changes seen following 3 h exposure to 0.5 MIC of ceftazidime, imipenem, panipenem, meropenem and biapenem, as evaluated by phase-contrast microscopy. Ceftazidime induced filament formation, as described previously.
Morphological changes induced by antibiotics
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When P. aeruginosa and S. marcescens were exposed to each carbapenem, a wide variety of morphological changes was observed. The morphological changes induced by antibiotics at 0.5 MIC were not affected by the magnitude of the MIC.
All strains of E. coli, K. pneumoniae, P. aeruginosa and Proteus spp., and 95% of S. marcescens exposed to imipenem became completely converted to ovoid or spherical cells. In one S. marcescen strain both spherical cells and 'oval-centred' cells were observed (Figure 1 , row D, panels 5 and 6).
All strains of E. coli, K. pneumoniae, P. aeruginosa and Proteus spp., and 90% of S. marcescens exposed to panipenem became converted to ovoid or spherical cells. Two S. marcescens strains had both ovoid cells and 'ovalcentred' cells. The changes induced by panipenem were largely similar to those induced by imipenem.
Of all the antibiotics studied, meropenem had the most variable effect on morphology. All strains of Proteus spp., 95% of E. coli, 85% of S. marcescens, 70% of K. pneumoniae and 5% of P. aeruginosa became converted to ovoid cells when exposed to meropenem, while the remaining E. coli, S. marcescens and K. pneumoniae showed the coexistence of ovoid/spherical cells and either filamentous (0%, 0% and 15%, respectively) or 'ovalcentred' cells (5%, 15% and 25%, respectively). The pneumoniae and Proteus spp., 90% of E. coli and 95% of S. marcescens became ovoid. Both ovoid/spherical and 'oval-centred' cells were seen in two E. coli strains and one S. marcescens strain. In P. aeruginosa isolates showed ovoid/spherical cells (45%), 'oval-centred' cells (35%), and the coexistence of ovoid and 'oval-centred' cells (20%). Figure 1 shows the typical morphological changes seen by SEM in E. coli, S. marcescens, K. pneumoniae, P. aeruginosa, P. vulgaris and P. mirabilis treated with each antibiotic. These changes were representative of those seen by phase-contrast microscopy. Ceftazidime induced formation of filaments, whereas carbapenems such as imipenem and panipenem induced formation of neither filamentous nor oval-centred cells, but oval/spheroid cells. Some P. aeruginosa isolates showed unique morphological changes, shorter 'oval-centred' cells by meropenem (Figure 1, D5 ) and longer 'oval-centred' cells by biapenem (Figure 1, D6 ). The rest of P. aeruginosa isolates contained ovoid or spherical cells by biapenem.
Antibiotic-induced release of endotoxin
The levels of endotoxin release induced by carbapenems and ceftazidime from clinical isolates are shown in Figure  2 . The endotoxin release after the 3 h exposure to antibiotics at 0.5 MIC was determined. Viable counts of bacteria at 3 h were in the range of 10 6 -10 8 cfu/mL. The amount of endotoxin released per bacterium, calculated by taking the bacterial numbers into account, is shown in Figure 2 . Except for P. aeruginosa, there were significant differences in the levels of endotoxin release between bacteria exposed to ceftazidime and those exposed to carbapenems (P 0.05). The levels of endotoxin released from P. aeruginosa exposed to biapenem were significantly higher than from those exposed to imipenem, panipenem or meropenem (P 0.030, 0.017 and 0.002, respectively). There was a relationship between these differences and the morphological changes; the former cultures contained filamentous cells and the latter ovoid/spherical. In P. aeruginosa, high levels of endotoxin were released after biapenem treatment, approaching that seen after ceftazidime treatment. Biapenem induced formation of longer 'oval-centred' cells. In conclusion, longer 'ovalcentred' cells produced more endotoxin than ovoid/ spherical and shorter 'oval-centred' cells.
Discussion
Recent in-vitro studies have shown that endotoxin is released when Gram-negative bacteria are exposed to antibiotics, including penicillins, 2, 7, 14 cephalosporins, 2, 4, 7, 8, 10, 11 carbapenems, 4, 8, 10, 11 monobactams, 8, 10 aminoglycosides 2,7,10,14 and quinolones. 7, 10, 13, 14 The amount of endotoxin release appears to be related to the morphological changes induced by the antibiotics. Recent studies observed carbapenem-induced morphological changes, especially with P. aeruginosa. 19, 21 In this study we demonstrated morphological changes in the five Gramnegative species exposed to ceftazidime or carbapenems at 0.5 MIC for 3 h, and a correlation between morphological change and endotoxin release. The filamentous cells and longer 'oval-centred' cells produced more 26 -Lactam antibiotics are known to differ in their PBP-binding specificities in E. coli and P. aeruginosa. For example, ceftazidime is a PBP-3 specific cephalosporin, and causes both filamentation and a high degree of endotoxin release due to the increased cell mass and continuing production of LPS by the cell. Imipenem, panipenem, and biapenem have high affinity for PBP-2 and relatively low affinity for PBP-1a, and cause conversion of the bacteria to round cells (spheroplasts). 11, 17, 18 Meropenem has high affinity for both PBP-2 and PBP-3, and induces formation of filaments, 'ovalcentred' cells or spheroplasts, depending on antibiotic concentration and exposure period. 19 Since most -lactam antibiotics bind to more than one PBP, the morphological changes induced by these antibiotics depend on the sum of the individual inhibition effects. The PBP-3:PBP-2 and PBP-3:PBP-1 inhibition ratios influence the length of filaments. 27 We demonstrated that 0.5 MIC of meropenem or biapenem could cause formation of filaments with or without an ovoid centre as well as formation of spherical cells in P. aeruginosa isolates. Therefore, the predominant binding site of these carbapenems is probably PBP-2 in some isolates and PBP-3 in others.
Clinical isolates used in this study included some strains resistant to ceftazidime, imipenem, panipenem, meropenem and/or biapenem. A K. pneumoniae strain was resistant to ceftazidime but not to carbapenems, because it constitutively produced plasmid-mediated AmpC-type -lactamase. 24, 25 Five strains of S. marcescens were resistant to both ceftazidime and carbapenems, in part because they produced a plasmid-mediated metallo--lactamase. 23 In the remaining resistant strains, however, the mechanisms of resistance have not been explained. Our results suggest that antibiotic-induced morphological changes with resistant strains exposed at 0.5 MIC are indistinguishable from those with the sensitive strains exposed at 0.5 MIC (data not shown).
Antibiotic-induced release of endotoxin is not always due to cell lysis, 11, 12, 19 as also shown in this study, but is enhanced by increase in bacterial biomass. Circulating levels of endotoxin may increase soon after antibiotic therapy is initiated. 5 Thus, clinicians should be cautious in using antibiotics that induce the causative pathogen to form filaments with or without an oval centre. As our invitro results indicate, however, one cannot predict the amount of endotoxin released, especially from P. aeruginosa, after exposure to selective carbapenems. Therefore, the risk of the endotoxin release should be considered seriously, even after treatment with some carbapenems for infections due to Gram-negative bacteria.
